Organogenesis
ORGO
$2.35
Share price
2.84%
Change (1 day)
14.63%
Change (1 year)
Categories
Organogenesis (ORGO) - Cash on Hand
Cash on Hand as of December 2023 : $0.10 B
According to Organogenesis's latest financial reports the company has $0.10 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Organogenesis - Cash on Hand chart (from 2016 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.10 B | 1.33% |
| 2022-12-31 | $0.10 B | -10.05% |
| 2021-12-31 | $0.11 B | 35% |
| 2020-12-31 | $84.39 M | 40.25% |
| 2019-12-31 | $60.17 M | 182.63% |
| 2018-12-31 | $21.29 M | 822.09% |
| 2017-12-31 | $2.3 M | 122% |
| 2016-12-31 | $1.04 M | 725.04% |
| 2015-12-31 | $0.12 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $95.88 M | -7.66% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.82 M | -79.95% | 🇺🇸 USA |